NEW COAS IN ONCOLOGY GUIDE
QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.
Read the GuideGive a voice to children and adolescents from five to eighteen years of age when assessing health-related quality of life. Access a wide selection of pediatric PRO measures to advance patient health in both clinical research and care settings.
QualityMetric’s pediatric-specific PRO health surveys capture, analyze and interpret health outcomes for a variety of conditions by coupling meaningful data with multidisciplinary research expertise to gain a deeper understanding of pediatric patient experiences and preferences.
Our suite of pediatric PRO measures include several HealthActCHQ instruments that provide scientifically validated insights commonly utilized in pharmaceutical clinical trials, government studies, and academic research. Examine health status for the full age continuum of populations by leveraging versatile pediatric assessments in your work.
Contact us for a review of our capabilities by phone at (800) 572-9394 or by filling out the form. For academic organizations click here.
Please answer the following questions and we will be in touch regarding your license
QualityMetric is reviewing your application and will get back to you shortly with approval to move forward with a license to administer, collect, score, and interpret the data for your project/study.
Next steps:
If you have started administering the survey, please email a copy of the survey being administered to [email protected]. We will QA the form for any changes that may affect the scoring and interpretation of the data collected. (Fees may apply).
If you are applying for a student license, please email a copy of your student ID to [email protected].
Available in over 200 languages across multiple modes of administration, our pediatric patient-reported outcome surveys help researchers and investigators integrate the voice of adolescents, children, toddlers and infants in studies and trials around the globe, giving a voice to children and their families across hundreds of disease conditions and studies. In addition to QualityMetric’s core pediatric experience, we recently added HealthActCHQ‘s portfolio of internationally recognized child and infant patient-reported outcome (PRO) legacy measures to further expand the patients’ perspectives in healthcare planning.
For assessing quality of life and functional health and well-being across all conditions ages infant to eighteen.
With a trusted network of linguists and translators offering extensive knowledge in end-to-end drug development and country-specific guidelines, we can facilitate intended translation interpretations for all target populations and enable an unbaised view of health outcomes and study results.
The principal surveys from our observer-reported (ObsRO) toolkit portfolio include the Child Health Questionnaire (CHQ) and the Infant Toddler Quality of Life (ITQOL)—legacy surveys focused on pediatric and adolescent health-related quality of life (HRQOL). These comprehensive measures assess the infant, child or adolescent’s physical, emotional and social well-being from the parent’s perspective and also capture the overall well-being of the parent and family. As recommended by the FDA, EMA, NICE and others, the CHQ is also available as a self-reported PRO measure.
For measurement relevant to patients’ unique experience of their disease and treatment with evidence of reliability, validity and the ability to detect change in the underlying disease.
For measurement that is specific to your project or condition-related goals, whether you require an entirely new PRO survey or modifications to an existing survey.
Learn MoreA comprehensive list of peer-reviewed manuscripts documenting the use of several pediatric-specific PRO health surveys from HealthActCHQ.
View NowComprised of multidisciplinary scientists, researchers and health experts around the globe, our team has decades of experience in diverse therapeutic areas, including:
Our high-quality, regulatory-compliant data will better inform your processes and improve your ability to address health-related outcomes.
For measurement relevant to patients’ unique experience of their disease and treatment with evidence of reliability, validity and the ability to detect change in the underlying disease.
Understand the full impact of diseases on patients and defined populations.
Make risk-adjusted comparisons across treatments, providers, programs and patients.
Evaluate unmet needs and identify opportunities to increase the length and quality of patients’ lives.
Predict the future health utilization and medical expenditures of certain patients.
Measure and monitor health improvement or decline as well as the velocity of change over time.
Incorporate the patient’s experience in product label and marketing claims.
Our PRO solutions can provide continuity in measurement across the continuum of product development, helping fill in gaps in clinical markers.
Our PRO solutions can provide continuity in measurement across the continuum of product development, helping fill in gaps in clinical markers.
